FDA backs Pfizer COVID boosters for seniors, high-risk

The US moved a step closer on Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots.

The US moved a step closer on Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots. September 23, 2021 at 07:05AM https://ift.tt/2ZcZHKr